来源
2007-8-1 10:19:05

Nature Medicine :干细胞能够帮助受伤而非老化的心脏再生

    生物谷:研究人员在8月号的《自然—医学》中报告,干细胞能够帮助受伤而非老化的心脏再生。

    心脏中的干细胞能否在心脏老化或受伤后再生出心脏细胞呢?这是长久以来一个颇有争论的话题。为了解决这个问题,Richard  Lee和同事采用一种全新的遗传学方法来解决以前研究中诸多的技术限制。他们培养了一种转基因小鼠,在这种小鼠的幼年期,将荧光蛋白质标签贴在其心脏细胞而不是心脏干细胞上。

    他们推测,如果心脏干细胞充满心脏,那么荧光心脏细胞的比例会随着时间的推移而减少;如果不是,那么这个比例应该是稳定不变的。他们在实验中发现,随着年龄的正常增加,荧光心脏细胞的比例没有变化。但相反,在遭受心脏病袭击或其他心脏受伤事件后,荧光心脏细胞的比例减少了。这说明心脏干细胞会在心脏受到伤害而非老化后会补充心脏细胞。

    新发现动摇了对心脏干细胞存在性的怀疑,然而,为什么心脏干细胞在受伤时和老化时表现出不同功能呢?这一机理有待科学家们进一步探索。(科学时报)

原始出处:

Nature Medicine
Published online: 29 July 2007 | doi:10.1038/nm1618

Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury

Patrick C H Hsieh1,3,4, Vincent F M Segers1,4, Michael E Davis1, Catherine MacGillivray1, Joseph Gannon1, Jeffery D Molkentin2, Jeffrey Robbins2 & Richard T Lee1

An emerging concept is that the mammalian myocardium has the potential to regenerate, but that regeneration might be too inefficient to repair the extensive myocardial injury that is typical of human disease1, 2, 3, 4, 5, 6, 7, 8. However, the degree to which stem cells or precursor cells contribute to the renewal of adult mammalian cardiomyocytes remains controversial. Here we report evidence that stem cells or precursor cells contribute to the replacement of adult mammalian cardiomyocytes after injury but do not contribute significantly to cardiomyocyte renewal during normal aging. We generated double-transgenic mice to track the fate of adult cardiomyocytes in a 'pulse-chase' fashion: after a 4-OH-tamoxifen pulse, green fluorescent protein (GFP) expression was induced only in cardiomyocytes, with 82.7% of cardiomyocytes expressing GFP. During normal aging up to one year, the percentage of GFP+ cardiomyocytes remained unchanged, indicating that stem or precursor cells did not refresh uninjured cardiomyocytes at a significant rate during this period of time. By contrast, after myocardial infarction or pressure overload, the percentage of GFP+ cardiomyocytes decreased from 82.8% in heart tissue from sham-treated mice to 67.5% in areas bordering a myocardial infarction, 76.6% in areas away from a myocardial infarction, and 75.7% in hearts subjected to pressure overload, indicating that stem cells or precursor cells had refreshed the cardiomyocytes.

  1. Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Cambridge, Massachusetts 02139, USA.
  2. Division of Molecular Cardiovascular Biology, Department of Pediatrics, Cincinnati Children's Hospital, University of Cincinnati, Cincinnati, Ohio 45229, USA.
  3. Present address: Institute of Clinical Medicine, National Cheng Kung University, Tainan City, Taiwan.
  4. These authors contributed equally to this work.

Correspondence to: Richard T Lee1 e-mail: rlee@partners.org

相关报道:

患病心脏的干细胞疗法

日本发现能使心肌再生的干细胞 心脏可以自己长

自体干细胞移植修复心脏

骨髓干细胞治疗心脏病?

试验证明干细胞心脏修复疗法有利有弊

干细胞治疗心脏病距临床广泛应用还有多远?

JCI:骨髓来源的间质干细胞能治疗心脏疾病

巴西利用干细胞治疗心脏病取得成果

德国科学家用干细胞改善心脏功能

 

  • 众说风云 (已有1条评论)

聚焦

二十年英杰在整合中前行!

Invitrogen董事长兼CEO:Gregory Lucier先生专访

Master

人物

成功的秘诀

Train to gain

招聘

为你的职业拓宽道路

分子生物学相关产品



定量PCR仪

Eppendorf Ep Master
定量PCR仪

实时定量PCR仪

ABI Stepone TM 实时定量PCR仪,最新的软件系统,界面友好,操作简单

PCR产物纯化

各种厂家和各种规格的PCR产物纯化试剂盒


定量PCR试剂

最全的定量PCR试剂


荧光定量PCR全套服务方案

从引物设计到实验全程服务